1
|
Arjona-Sanchez A, Aziz O, Passot G, Salti G, Serrano A, Esquivel J, Van der Speeten K, Sommariva A, Kazi M, Shariff U, Martínez-Regueira F, Piso P, Yonemura Y, Turaga K, Sgarbura O, Avanish Saklani A, Tonello M, Rodriguez-Ortiz L, Vazquez-Borrego MC, Romero-Ruiz A, Glehen O. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry. Eur J Surg Oncol 2023; 49:107001. [PMID: 37579618 DOI: 10.1016/j.ejso.2023.107001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2023] [Revised: 07/07/2023] [Accepted: 07/29/2023] [Indexed: 08/16/2023]
Abstract
The laparoscopic approach for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (L-CRS + HIPEC) in highly selected patients was previously reported from the PSOGI registry with a demonstrable reduction in length of stay and post-operative morbidity. This study aims to update this international PSOGI registry with a larger cohort of patients and a longer follow-up period. METHODS An international registry was designed through a networking database (REDCAP®). All centers performing L-CRS + HIPEC were invited through PSOGI to submit data on their cases. Variables such as demographics, clinical outcomes, and survival were analyzed. RESULTS A total of 315 L-CRS + HIPEC cases were provided by 14 worldwide centers. A total of 215 patients were included in the L-CRS + HIPEC group. The median peritoneal cancer index (PCI) was 3 (3-5). The median length of stay was 7 days (5-10) and the major morbidity (Clavien-Dindo ≥3) was 6.1% after 30 days. The 5-year disease-free survival (DFS) per tumor origin was: 94% for PMP-LG, 85% for PMP-HG, 100% for benign multicyst peritoneal mesothelioma (MPM), 37.4% for colonic origin, and 54%(at 3 years) for ovarian origin. The 5 years overall survival (OS) per tumor origin was: 100% for PMP-LG, PMP-HG and MPM; 61% for colonic origin, and 74% (at 3 years) for ovarian origin. In addition, a total of 85 patients were analyzed in the laparoscopic risk-reducing HIPEC (L-RR + HIPEC). The median length of stay was 5 days (4-6) and the major morbidity was 6% after 30 days. The 5-year DFS per tumor origin was: 96% for perforated low grade appendiceal mucinous neoplasm (LAMN II) and 68.1% for colon origin. The 5 years OS per tumor origin was: 98% for LAMN II and 83.5% for colonic origin. CONCLUSIONS Minimally invasive CRS + HIPEC is a safe procedure for selected patients with peritoneal carcinomatosis in specialized centers. It improves perioperative results while providing satisfactory oncologic outcomes. L-RR + HIPEC represents a promising strategy that could be evaluated in patients with high risk of developing peritoneal carcinomatosis into prospective randomized trials.
Collapse
Affiliation(s)
- A Arjona-Sanchez
- Unit of Surgical Oncology, Reina Sofia University Hospital, Cordoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group. Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, University of Cordoba, Córdoba, Spain.
| | - O Aziz
- Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, UK
| | - G Passot
- Department of Surgical Oncology, Hospices Civils de Lyon, Lyon, France
| | - G Salti
- Department of Surgical Oncology, Edward-Elmhurst Health, Naperville, IL, USA; The University of Illinois, Chicago, USA
| | - A Serrano
- Unit of Surgical Oncology, University Hospital Fuenlabrada, Madrid, Spain
| | | | | | - A Sommariva
- Advanced Surgical Oncology Unit, Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
| | - M Kazi
- Gastrointestinal Surgical Oncology, Tata Memorial Hospital, Mumbai. Homi Bhabha National Institute, Mumbai. Advanced Centre for Treatment, Research, And Education in Cancer, India
| | - U Shariff
- University Hospitals Birmingham NHS Foundation Trust and Birmingham Peritoneal Malignancy Unit, Good Hope Hospital, Birmingham, UK
| | | | - P Piso
- Department for General and Visceral Surgery, Krankenhaus Barmherzige Brueder Regensburg, Germany
| | | | - K Turaga
- Department of Surgery, Yale University School of Medicine, USA
| | - O Sgarbura
- Unit of Surgical Oncology, Institut Du Cancer Montpellier, France
| | - A Avanish Saklani
- Gastrointestinal Surgical Oncology, Tata Memorial Hospital, Mumbai. Homi Bhabha National Institute, Mumbai. Advanced Centre for Treatment, Research, And Education in Cancer, India
| | - M Tonello
- Advanced Surgical Oncology Unit, Surgical Oncology of the Esophagus and Digestive Tract, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
| | - L Rodriguez-Ortiz
- Unit of Surgical Oncology, Reina Sofia University Hospital, Cordoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group. Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, University of Cordoba, Córdoba, Spain
| | - M C Vazquez-Borrego
- Unit of Surgical Oncology, Reina Sofia University Hospital, Cordoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group. Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, University of Cordoba, Córdoba, Spain
| | - A Romero-Ruiz
- Unit of Surgical Oncology, Reina Sofia University Hospital, Cordoba, Spain; GE09 Research in Peritoneal and Retroperitoneal Oncologic Surgery Group. Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Department of Biochemistry and Molecular Biology, University of Cordoba, Córdoba, Spain
| | - O Glehen
- Department of Surgical Oncology, Hospices Civils de Lyon, Lyon, France
| |
Collapse
|
2
|
Dickson A, Mullooly N, Serrano A, Escudero-Ibarz L, Wiggins C, Gianni D. Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells. SLAS Discov 2023; 28:29-35. [PMID: 36649793 DOI: 10.1016/j.slasd.2023.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Revised: 11/27/2022] [Accepted: 01/10/2023] [Indexed: 01/15/2023]
Abstract
Small airway epithelial cells (SAECs) play a central role in the pathogenesis of lung diseases and are now becoming a crucial cellular model for target identification and validation in drug discovery. However, primary cell lines such as SAECs are often difficult to transfect using traditional lipofection methods; therefore, gene editing using CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 is often carried out through ribonucleoprotein (RNP) electroporation. Here we have established a robust, scalable, and automated arrayed CRISPR nuclease (CRISPRn) screening workflow for SAECs which can be combined with a myriad of disease-specific endpoint assays.
Collapse
Affiliation(s)
- Anna Dickson
- Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom.
| | - Niamh Mullooly
- Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom
| | - Alessia Serrano
- Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom
| | - Leire Escudero-Ibarz
- Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom
| | - Ceri Wiggins
- Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom
| | - Davide Gianni
- Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB2 0AA, United Kingdom.
| |
Collapse
|
3
|
Granados-Miralles C, Serrano A, Prieto P, Guzmán-Mínguez J, Prieto J, Friedel A, García-Martín E, Fernández J, Quesada A. Quantifying Li-content for Compositional Tailoring of Lithium Ferrite Ceramics. Ann Ital Chir 2023. [DOI: 10.1016/j.jeurceramsoc.2023.02.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|
4
|
Díaz-Cambronero O, Serrano A, Abad-Gurumeta A, Garutti Martinez I, Esteve N, Alday E, Ferrando C, Mazzinari G, Vila-Caral P, Errando Oyonarte CL. Perioperative neuromuscular blockade. 2020 update of the SEDAR (Sociedad Española de Anestesiología y Reanimación) recommendations. Rev Esp Anestesiol Reanim (Engl Ed) 2023; 70:37-50. [PMID: 36621572 DOI: 10.1016/j.redare.2022.02.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Accepted: 02/16/2022] [Indexed: 01/07/2023]
Abstract
We present an update of the 2020 Recommendations on neuromuscular blockade of the SEDAR. The previous ones dated 2009. A modified Delphi consensus analysis (experts, working group, and previous extensive bibliographic revision) 10 recommendations were produced1: neuromuscular blocking agents were recommended for endotracheal intubation and to avoid faringo-laryngeal and tracheal lesions, including critical care patients.2 We recommend not to use neuromuscular blocking agents for routine insertion of supraglotic airway devices, and to use it only in cases of airway obstruction or endotracheal intubation through the device.3 We recommend to use a rapid action neuromuscular blocking agent with an hypnotic in rapid sequence induction of anesthesia.4 We recommend profound neuromuscular block in laparoscopic surgery.5 We recommend quantitative monitoring of neuromuscular blockade during the whole surgical procedure, provided neuromuscular blocking agents have been used.6 We recommend quantitative monitoring through ulnar nerve stimulation and response evaluation of the adductor pollicis brevis, acceleromyography being the clinical standard.7 We recommend a recovery of neuromuscular block of at least TOFr ≥ 0.9 to avoid postoperative residual neuromuscular blockade.8 We recommend drug reversal of neuromuscular block at the end of general anesthetic, before extubation, provided a TOFr ≥ 0.9 has not been reached.9 We recommend to choose anticholinesterases for neuromuscular block reversal only if TOF≥2 and a TOFr ≥ 0.9 has not been attained.10 We recommend to choose sugammadex instead of anticholinesterases for reversal of neuromuscular blockade induced with rocuronium.
Collapse
Affiliation(s)
- O Díaz-Cambronero
- Hospital Universitari Politécnic La Fe, Grupo de Investigación Medicina Perioperatoria, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
| | - A Serrano
- Hospital Ramón y Cajal, Madrid, Spain.
| | | | | | - N Esteve
- Hospital Son Espases, Palma de Mallorca, Mallorca, Spain.
| | - E Alday
- Hospital de La Princesa, Madrid, Spain.
| | | | - G Mazzinari
- Hospital Universitari Politécnic La Fe, Grupo de Investigación Medicina Perioperatoria, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
| | - P Vila-Caral
- Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.
| | - C L Errando Oyonarte
- Hospital Can Misses, Ibiza, Islas Baleares, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
| |
Collapse
|
5
|
Llau JV, Ferrandis R, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A, Quintana M, Amezaga R, Geroi M, Serrano A, Marcos P. SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients. Med Intensiva 2021; 45:567-568. [PMID: 34776407 PMCID: PMC8542454 DOI: 10.1016/j.medine.2021.10.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Accepted: 08/16/2020] [Indexed: 11/29/2022]
Affiliation(s)
- J V Llau
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), Spain; Hospital Universitari Doctor Peset, Valencia, Spain.
| | - R Ferrandis
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), Spain; Hospital Universitari i Politècnic La Fe, Valencia, Spain
| | - P Sierra
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), Spain; Fundació Puigver, Barcelona, Spain
| | - F Hidalgo
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), Spain; Clínica Universidad de Navarra, Pamplona, Spain
| | - C Cassinello
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), Spain; Hospital Universitario Miguel Servet, Zaragoza, Spain
| | - A Gómez-Luque
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), Spain; Hospital Universitario Virgen de la Victoria, Málaga, Spain
| | - M Quintana
- Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), Spain; Hospital Universitario La Paz-Carlos III, Madrid, Spain
| | - R Amezaga
- Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), Spain; Hospital Universitario Son Espases, Palma de Mallorca, Spain
| | - M Geroi
- Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), Spain; Hospital Universitario de Burgos, Burgos, Spain
| | - A Serrano
- Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), Spain; Hospital Clínico Universitario, Valencia, Spain
| | - P Marcos
- Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), Spain; Hospital Germans Trias i Pujol, Badalona, Spain
| |
Collapse
|
6
|
Pinto-Ibieta F, Serrano A, Cea M, Ciudad G, Fermoso FG. Beyond PHA: Stimulating intracellular accumulation of added-value compounds in mixed microbial cultures. Bioresour Technol 2021; 337:125381. [PMID: 34120059 DOI: 10.1016/j.biortech.2021.125381] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Revised: 06/01/2021] [Accepted: 06/02/2021] [Indexed: 06/12/2023]
Abstract
This review compiled and analyzed the operational conditions (dissolved oxygen, feast and famine ratio, sequential batch reactor cycle length, organic loading rate (OLR), pH, C/N, and temperature) established during the feast and famine culture strategy for the mixed microbial cultures (MMC) selection to understand how these variables could affect the synthesis of polyhydroxyalkanoates, polyglucose, triacylglycerides, levulinic acid and adipic acid from non-fermented substrates. According to the reported information, the dissolved oxygen has a greater impact on the type and amount of produced compound. In a lesser extent, the OLR and the cycle length were identified to have an impact on the accumulation of polyhydroxyalkanoates, whose accumulation was favored at lower OLR and longer cycle lengths. Thereby, the information of this work will allow the design of future strategies for the simultaneous accumulation of compounds of interest other than the polyhydroxyalkanoates or understand the operational conditions that would optimize the polyhydroxyalkanoates production.
Collapse
Affiliation(s)
- F Pinto-Ibieta
- Departamento de Ingeniería Química, Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Temuco, Chile; Departamento de Procesos Industriales, Facultad de Ingeniería, Universidad Católica de Temuco, Casilla 15-D, Temuco, Chile
| | - A Serrano
- Instituto de la Grasa. Consejo Superior de Investigaciones Científicas. Campus Universitario Pablo de Olavide- Ed. 46, Ctra. de Utrera, km. 1, Seville 41013, Spain.
| | - M Cea
- Departamento de Ingeniería Química, Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Temuco, Chile; Scientific and Technological Bioresource Nucleus (BIOREN), Universidad de La Frontera, Temuco, Chile
| | - G Ciudad
- Departamento de Ingeniería Química, Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Temuco, Chile; Scientific and Technological Bioresource Nucleus (BIOREN), Universidad de La Frontera, Temuco, Chile; Instituto del Medio Ambiente (IMA), Universidad de La Frontera, Avenida Francisco Salazar #01145, Temuco, Chile
| | - F G Fermoso
- Instituto de la Grasa. Consejo Superior de Investigaciones Científicas. Campus Universitario Pablo de Olavide- Ed. 46, Ctra. de Utrera, km. 1, Seville 41013, Spain
| |
Collapse
|
7
|
Hartmann J, Kopp HG, Budach V, Grünwald V, Wölfel T, Kluba T, Rudert M, Melcher I, Micke O, Kürschner D, Herbst R, Hertenstein B, Blau W, Serrano A, Groth J, Kunitz A. 1528P Prospective IAWS registry to optimize either neo- or adjuvant treatment strategies for adult patients with large sized, high grade soft tissue sarcoma (NRSTS). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.858] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
8
|
Serrano A, Rodríguez-Jurado D, Román B, Bejarano-Alcázar J, De la Rosa R, León L. Verticillium Wilt Evaluation of Olive Breeding Selections Under Semi-Controlled Conditions. Plant Dis 2021; 105:1781-1790. [PMID: 33174802 DOI: 10.1094/pdis-08-20-1829-re] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Genetic resistance is the most recommended measure to control verticillium wilt in olive (VWO), a vascular disease caused by the soil-borne fungus Verticillium dahliae, which has promoted the development of olive breeding programs aimed at obtaining new resistant and highly yielding cultivars in recent years. Screening has been commonly performed under controlled conditions in grow chamber after artificial inoculation during the early stage of breeding programs, but additional evaluation is necessary to confirm previous results as well as to test for additional agronomic traits. During this study, 20 breeding selections initially classified as resistant to the disease have been re-evaluated in artificially infested soils under natural environmental conditions. The maximum disease incidence (52.6%) was reached at 26 months after planting, and the disease intensity index reached the maximum value of 38.5% at 29 months after planting. Nine breeding selections consistently confirmed the previous results regarding resistance to V. dahliae infection; however, contradictory results, compared with those of previous evaluations under controlled conditions in grow chambers, were obtained for the rest of selections tested, thereby underlining the need for long-term experimentation under natural environmental conditions. Additional positive agronomic traits, such as early bearing, were also observed for some of the resistant selections, but plant vigor varied. Some seem highly promising for release as new cultivars when characterization of other important agronomic traits is completed in the future.
Collapse
Affiliation(s)
- A Serrano
- The Andalusian Institute of Agriculture and Fishery Research and Training (IFAPA), Alameda del Obispo, Avenida Menéndez Pidal, Córdoba, Spain
| | - D Rodríguez-Jurado
- The Andalusian Institute of Agriculture and Fishery Research and Training (IFAPA), Alameda del Obispo, Avenida Menéndez Pidal, Córdoba, Spain
| | - B Román
- The Andalusian Institute of Agriculture and Fishery Research and Training (IFAPA), Alameda del Obispo, Avenida Menéndez Pidal, Córdoba, Spain
| | - J Bejarano-Alcázar
- The Andalusian Institute of Agriculture and Fishery Research and Training (IFAPA), Alameda del Obispo, Avenida Menéndez Pidal, Córdoba, Spain
| | - R De la Rosa
- The Andalusian Institute of Agriculture and Fishery Research and Training (IFAPA), Alameda del Obispo, Avenida Menéndez Pidal, Córdoba, Spain
| | - L León
- The Andalusian Institute of Agriculture and Fishery Research and Training (IFAPA), Alameda del Obispo, Avenida Menéndez Pidal, Córdoba, Spain
| |
Collapse
|
9
|
Nogales F, Ojeda ML, Serrano A, Rua RM, Carreras O. Metabolic syndrome during gestation and lactation: An important renal problem in dams. selenium renal clearance. J Trace Elem Med Biol 2021; 64:126709. [PMID: 33387739 DOI: 10.1016/j.jtemb.2020.126709] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2020] [Revised: 12/11/2020] [Accepted: 12/16/2020] [Indexed: 12/17/2022]
Abstract
BACKGROUND Metabolic syndrome (MS) in lactating dams leads to several cardiometabolic changes related to selenium (Se) status and selenoproteins expression which produce hypertension. However, little is known about the state of these dams' kidney functions and their Se deposits. METHODS Two experimental groups of dam rats were used: control (Se: 0.1 ppm) and MS (Fructose 65 % and Se: 0.1 ppm). At the end of lactation (21d postpartum) kidney weight and protein content, Se deposits, and the activity of the antioxidant selenoprotein glutathione peroxidase (GPx) were measured in dams. Kidney functional parameters: albuminuria, creatinine clearance, serum aldosterone and uric acid levels and water and electrolyte (Na+ and K+) balance were also evaluated. Systolic blood pressure (SBP) was measured. RESULTS In MS dams at the end of lactation Se deposits and GPx activity are higher in the kidney; however, lipid renal peroxidation appears, relative Se clearance increases, and the dams have lost Se by urine. MS dams have polyuria and polydipsia, high uric acid serum levels, albuminuria and high creatinine clearance, implying glomerular renal malfunction with protein loss. They also present hypernatremia, hypokalemia and hyperaldosteronemia, leading to high SBP; however, a natriuretic process is taking place. CONCLUSION Since these alterations appear, at least in part, to be related to oxidative stress in renal cells, Se supplementation could be beneficial to avoiding greater lipid renal oxidation during lactation.
Collapse
Affiliation(s)
- F Nogales
- Department of Physiology, Faculty of Pharmacy, Seville University, 41012, Seville, Spain
| | - M L Ojeda
- Department of Physiology, Faculty of Pharmacy, Seville University, 41012, Seville, Spain.
| | - A Serrano
- Department of Physiology, Faculty of Pharmacy, Seville University, 41012, Seville, Spain
| | - R M Rua
- Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal
| | - O Carreras
- Department of Physiology, Faculty of Pharmacy, Seville University, 41012, Seville, Spain
| |
Collapse
|
10
|
Casco N, Jorge AL, Palmero D, Alffenaar JW, Fox G, Ezz W, Cho JG, Skrahina A, Solodovnikova V, Bachez P, Arbex MA, Galvão T, Rabahi M, Pereira GR, Sales R, Silva DR, Saffie MM, Miranda RC, Cancino V, Carbonell M, Cisterna C, Concha C, Cruz A, Salinas NE, Revillot ME, Farias J, Fernandez I, Flores X, Gallegos P, Garavagno A, Guajardo C, Bahamondes MH, Merino LM, Muñoz E, Muñoz C, Navarro I, Navarro J, Ortega C, Palma S, Pardenas AM, Pereira G, Castillo PP, Pinto M, Pizarro R, Rivas F, Rodriguez P, Sánchez C, Serrano A, Soto A, Taiba C, Venegas M, Vergara MS, Vilca E, Villalon C, Yucra E, Li Y, Cruz A, Guelvez B, Plaza R, Tello K, Andréjak C, Blanc FX, Dourmane S, Froissart A, Izadifar A, Rivière F, Schlemmer F, Gupta N, Ish P, Mishra G, Sharma S, Singla R, Udwadia ZF, Manika K, Diallo BD, Hassane-Harouna S, Artiles N, Mejia LA, Alladio F, Calcagno A, Centis R, Codecasa LR, D Ambrosio L, Formenti B, Gaviraghi A, Giacomet V, Goletti D, Gualano G, Kuksa L, Danila E, Diktanas S, Miliauskas S, Ridaura RL, López F, Torrico MM, Rendon A, Akkerman OW, Piubello A, Souleymane MB, Aizpurua E, Gonzales R, Jurado J, Loban A, Aguirre S, de Egea V, Irala S, Medina A, Sequera G, Sosa N, Vázquez F, Manga S, Villanueva R, Araujo D, Duarte R, Marques TS, Grecu VI, Socaci A, Barkanova O, Bogorodskaya M, Borisov S, Mariandyshev A, Kaluzhenina A, Stosic M, Beh D, Ng D, Ong C, Solovic I, Dheda D, Gina P, Caminero JA, Cardoso-Landivar J, de Souza Galvão ML, Dominguez-Castellano A, García-García JM, Pinargote IM, Fernandez SQ, Sánchez-Montalvá A, Huguet ET, Murguiondo MZ, Bruchfeld J, Bart PA, Mazza-Stalder J, Tiberi S, Arrieta F, Heysell S, Logsdon J, Young L. TB and COVID-19 co-infection: rationale and aims of a global study. Int J Tuberc Lung Dis 2021; 25:78-80. [PMID: 33384052 DOI: 10.5588/ijtld.20.0786] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
| | | | | | | | - G Fox
- New South Wales, Australia
| | - W Ezz
- New South Wales, Australia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Caroca E, Serrano A, Borja R, Jiménez A, Carvajal A, Braga AFM, Rodriguez-Gutierrez G, Fermoso FG. Influence of phenols and furans released during thermal pretreatment of olive mill solid waste on its anaerobic digestion. Waste Manag 2021; 120:202-208. [PMID: 33310132 DOI: 10.1016/j.wasman.2020.11.027] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/17/2020] [Revised: 10/13/2020] [Accepted: 11/04/2020] [Indexed: 06/12/2023]
Abstract
The application of thermal pretreatments to facilitate its anaerobic digestion has associated phenols and furans production, which are commonly identified as inhibitory compounds. Phenols and furans extraction can be done from a liquid phase produced after the thermal pretreatment. In the present study this dephenolized liquid phase (DLP) showed an increase of 42% in methane yield compared to the raw liquid phase (LP) demonstrating the inhibitor character of such compounds. The main extracted phenols and furans were: 3,4-Dihydroxyphenylglycol (DHPG), Hydroxytyrosol (HT), Tyrosol (Ty), Vanillic acid (AcV), Hydroxymethylfurfural (HMF), Vanillin (V) and Furfural (F).This study also aimed to evaluate the individual effect on methane production of these specific phenols and furans the within the mixture of several ones from LP. The evaluation of the individual compounds over the methanogenesis of a dephenolized liquid phase showed that only V was inhibitory on both methane yield and methane production rate. HMF had a significantly negative effect on methane yield, but improved the methane production rate instead. Ty, F, DHPG and HT favoured the methane yield and production rate. Additionally, it was observed that negative effect of some individual phenols and furans was counteracted by the positive effect of other compounds.
Collapse
Affiliation(s)
- E Caroca
- Universidad Técnica Federico Santa María, Avenida Vicuña Mackenna 3939 San Joaquín, Santiago, Chile; Universidad Pablo de Olavide, Carretera de Utrera, 1, 41013 Seville, Spain
| | - A Serrano
- Instituto de la Grasa (CSIC), Seville, Spain; School of Civil Engineering, The University of Queensland, Campus St Lucia, Ed. 49, CP 4067, Brisbane, Australia
| | - R Borja
- Instituto de la Grasa (CSIC), Seville, Spain
| | - A Jiménez
- Universidad Pablo de Olavide, Carretera de Utrera, 1, 41013 Seville, Spain
| | - A Carvajal
- Universidad Técnica Federico Santa María, Avenida Vicuña Mackenna 3939 San Joaquín, Santiago, Chile.
| | - A F M Braga
- Center for Research, Development and Innovation in Environmental Engineering, São Carlos School of Engineering (EESC), University of São Paulo (USP), Engenharia Ambiental - Bloco 4-F, Av. João Dagnone, 1100 - Santa Angelina, 13.563-120, São Carlos, SP, Brazil
| | | | - F G Fermoso
- Instituto de la Grasa (CSIC), Seville, Spain
| |
Collapse
|
12
|
Gonzalez Fernandez M, Sanz Paris A, Arbones Mainar J, Perez Nogueras J, Torres Anoro E, Ferrer Lahuerta E, Serrano A. Relationship between relaxation masseter muscle thickness measured by ultrasound and dyspahgya in institutionalized elderly individuals. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
13
|
Llau JV, Ferrandis R, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A, Quintana M, Amezaga R, Geroi M, Serrano A, Marcos P. SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients. Med Intensiva 2020; 45:S0210-5691(20)30272-2. [PMID: 33023765 PMCID: PMC7474905 DOI: 10.1016/j.medin.2020.08.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Accepted: 08/16/2020] [Indexed: 11/24/2022]
Affiliation(s)
- J V Llau
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), España; Hospital Universitari Doctor Peset, Valencia, España.
| | - R Ferrandis
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), España; Hospital Universitari i Politècnic La Fe, Valencia, España
| | - P Sierra
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), España; Fundació Puigver, Barcelona, España
| | - F Hidalgo
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), España; Clínica Universidad de Navarra, Pamplona, España
| | - C Cassinello
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), España; Hospital Universitario Miguel Servet, Zaragoza, España
| | - A Gómez-Luque
- Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), España; Hospital Universitario Virgen de la Victoria, Málaga, España
| | - M Quintana
- Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), España; Hospital Universitario La Paz-Carlos III, Madrid, España
| | - R Amezaga
- Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), España; Hospital Universitario Son Espases, Palma de Mallorca, España
| | - M Geroi
- Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), España; Hospital Universitario de Burgos, Burgos, España
| | - A Serrano
- Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), España; Hospital Clínico Universitario, Valencia, España
| | - P Marcos
- Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), España; Hospital Germans Trias i Pujol, Badalona, España
| |
Collapse
|
14
|
Llau J, Ferrandis R, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A, Quintana M, Amezaga R, Gero M, Serrano A, Marcos P. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection. Revista Española de Anestesiología y Reanimación (English Edition) 2020. [PMCID: PMC7402104 DOI: 10.1016/j.redare.2020.05.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The infection by the coronavirus SARS-CoV-2, which causes the disease called COVID-19, mainly causes alterations in the respiratory system. In severely ill patients, the disease often evolves into an acute respiratory distress syndrome that can predispose patients to a state of hypercoagulability, with thrombosis at both venous and arterial levels. This predisposition presents a multifactorial physiopathology, related to hypoxia as well as to the severe inflammatory process linked to this pathology, including the additional thrombotic factors present in many of the patients. In view of the need to optimise the management of hypercoagulability, the working groups of the Scientific Societies of Anaesthesiology-Resuscitation and Pain Therapy (SEDAR) and of Intensive, Critical Care Medicine and Coronary Units (SEMICYUC) have developed a consensus to establish guidelines for actions to be taken against alterations in haemostasis observed in severely ill patients with COVID-19. These recommendations include prophylaxis of venous thromboembolic disease in these patients, and in the peripartum, management of patients on long-term antiplatelet or anticoagulant treatment, bleeding complications in the course of the disease, and the interpretation of general alterations in haemostasis.
Collapse
|
15
|
Llau JV, Ferrandis R, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A, Quintana M, Amezaga R, Gero M, Serrano A, Marcos P. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection. Rev Esp Anestesiol Reanim (Engl Ed) 2020; 67:391-399. [PMID: 32591185 PMCID: PMC7245242 DOI: 10.1016/j.redar.2020.05.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/03/2020] [Revised: 05/06/2020] [Accepted: 05/10/2020] [Indexed: 01/08/2023]
Abstract
The infection by the coronavirus SARS-CoV-2, which causes the disease called COVID-19, mainly causes alterations in the respiratory system. In severely ill patients, the disease often evolves into an acute respiratory distress syndrome that can predispose patients to a state of hypercoagulability, with thrombosis at both venous and arterial levels. This predisposition presents a multifactorial physiopathology, related to hypoxia as well as to the severe inflammatory process linked to this pathology, including the additional thrombotic factors present in many of the patients. In view of the need to optimise the management of hypercoagulability, the working groups of the Scientific Societies of Anaesthesiology-Resuscitation and Pain Therapy (SEDAR) and of Intensive, Critical Care Medicine and Coronary Units (SEMICYUC) have developed a consensus to establish guidelines for actions to be taken against alterations in haemostasis observed in severely ill patients with COVID-19. These recommendations include prophylaxis of venous thromboembolic disease in these patients, and in the peripartum, management of patients on long-term antiplatelet or anticoagulant treatment, bleeding complications in the course of the disease, and the interpretation of general alterations in haemostasis.
Collapse
Affiliation(s)
- J V Llau
- Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Hospital Universitari Doctor Peset, SEDAR, Valencia, España.
| | - R Ferrandis
- Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Hospital Universitari i Politècnic La Fe, SEDAR, Valencia, España
| | - P Sierra
- Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Fundació Puigvert, SEDAR , Barcelona, España
| | - F Hidalgo
- Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Clínica Universidad de Navarra, SEDAR, Pamplona, Navarra, España
| | - C Cassinello
- Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Hospital Universitario Miguel Servet, SEDAR, Zaragoza, España
| | - A Gómez-Luque
- Servicio de Anestesiología-Reanimación y Terapéutica del Dolor, Hospital Universitario Virgen de la Victoria, SEDAR, Málaga, España
| | - M Quintana
- Servicio de Medicina Intensiva, Hospital Universitario La Paz-Carlos III, SEMICYUC, Madrid, España
| | - R Amezaga
- Servicio de Medicina Intensiva, Hospital Universitario Son Espases, SEMICYUC, Palma de Mallorca, Baleares, España
| | - M Gero
- Servicio de Medicina Intensiva, Hospital Universitario, SEMICYUC, Burgos, España
| | - A Serrano
- Servicio de Medicina Intensiva, Hospital Clínico Universitario, SEMICYUC, Valencia, España
| | - P Marcos
- Servicio de Medicina Intensiva, Hospital Germans Trias i Pujol, SEMICYUC, Badalona, Barcelona, España
| |
Collapse
|
16
|
Muñoz D, Marcano L, Martín-Rodríguez R, Simonelli L, Serrano A, García-Prieto A, Fdez-Gubieda ML, Muela A. Magnetosomes could be protective shields against metal stress in magnetotactic bacteria. Sci Rep 2020; 10:11430. [PMID: 32651449 PMCID: PMC7351786 DOI: 10.1038/s41598-020-68183-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2019] [Accepted: 06/19/2020] [Indexed: 11/09/2022] Open
Abstract
Magnetotactic bacteria are aquatic microorganisms with the ability to biomineralise membrane-enclosed magnetic nanoparticles, called magnetosomes. These magnetosomes are arranged into a chain that behaves as a magnetic compass, allowing the bacteria to align in and navigate along the Earth’s magnetic field lines. According to the magneto-aerotactic hypothesis, the purpose of producing magnetosomes is to provide the bacteria with a more efficient movement within the stratified water column, in search of the optimal positions that satisfy their nutritional requirements. However, magnetosomes could have other physiological roles, as proposed in this work. Here we analyse the role of magnetosomes in the tolerance of Magnetospirillum gryphiswaldense MSR-1 to transition metals (Co, Mn, Ni, Zn, Cu). By exposing bacterial populations with and without magnetosomes to increasing concentrations of metals in the growth medium, we observe that the tolerance is significantly higher when bacteria have magnetosomes. The resistance mechanisms triggered in magnetosome-bearing bacteria under metal stress have been investigated by means of x-ray absorption near edge spectroscopy (XANES). XANES experiments were performed both on magnetosomes isolated from the bacteria and on the whole bacteria, aimed to assess whether bacteria use magnetosomes as metal storages, or whether they incorporate the excess metal in other cell compartments. Our findings reveal that the tolerance mechanisms are metal-specific: Mn, Zn and Cu are incorporated in both the magnetosomes and other cell compartments; Co is only incorporated in the magnetosomes, and Ni is incorporated in other cell compartments. In the case of Co, Zn and Mn, the metal is integrated in the magnetosome magnetite mineral core.
Collapse
Affiliation(s)
- D Muñoz
- Dpto. de Inmunología, Microbiología y Parasitología, Universidad del País Vasco - UPV/EHU, 48940, Leioa, Spain
| | - L Marcano
- Dpto. de Electricidad y Electrónica, Universidad del País Vasco - UPV/EHU, 48940, Leioa, Spain.,Helmholtz-Zentrum Berlin für Materialen und Energie, Berlin, Germany
| | - R Martín-Rodríguez
- QUIPRE Department, University of Cantabria, 39005, Santander, Spain.,Nanomedicine Group, IDIVAL, 39011, Santander, Spain
| | - L Simonelli
- CLAESS beamline, ALBA Synchrotron, 08290, Cerdanyola del Vallès, Spain
| | - A Serrano
- SpLine, Spanish CRG BM25 Beamline, ESRF, 38000, Grenoble, France
| | - A García-Prieto
- Dpto. de Física Aplicada I, Universidad del País Vasco - UPV/EHU, 48013, Bilbao, Spain.,BCMaterials, UPV/EHU Science Park, 48940, Leioa, Spain
| | - M L Fdez-Gubieda
- Dpto. de Electricidad y Electrónica, Universidad del País Vasco - UPV/EHU, 48940, Leioa, Spain.,BCMaterials, UPV/EHU Science Park, 48940, Leioa, Spain
| | - A Muela
- Dpto. de Inmunología, Microbiología y Parasitología, Universidad del País Vasco - UPV/EHU, 48940, Leioa, Spain. .,BCMaterials, UPV/EHU Science Park, 48940, Leioa, Spain.
| |
Collapse
|
17
|
Esteban M, Prieto L, Álvarez-Ossorio J, Gómez A, Cortiñas J, Serrano A, Cózar J. Urological recommendations regarding surgical care of suspected or confirmed SARS-CoV-2 or COVID-19+ patients. Actas Urológicas Españolas (English Edition) 2020. [PMCID: PMC7831435 DOI: 10.1016/j.acuroe.2020.07.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
18
|
Luque L, Rodrigo T, García-García JM, Casals M, Millet JP, Caylà J, Orcau A, Agüero R, Alcázar J, Altet N, Altube L, Álvarez F, Anibarro L, Barrón M, Bermúdez P, Bikuña E, Blanquer R, Borderías L, Bustamante A, Calpe J, Caminero J, Cañas F, Casas F, Casas X, Cases E, Castejón N, Castrodeza R, Cebrián J, Cervera A, Ciruelos J, Delgado A, De Souza M, Díaz D, Domínguez M, Fernández B, Gallardo J, Gallego M, Clemente MG, García C, García F, Garros F, Gort A, Guerediaga A, Gullón J, Hidalgo C, Iglesias M, Jiménez G, Jiménez M, Kindelan J, Laparra J, López I, Lera R, Lloret T, Marín M, Lacasa XM, Martínez E, Martínez A, Medina J, Melero C, Milà C, Millet J, Mir I, Molina F, Morales C, Morales M, Moreno A, Moreno V, Muñoz A, Muñoz C, Muñoz J, Muñoz L, Oribe M, Parra I, Penas A, Pérez J, Rivas P, Rodríguez J, Ruiz-Manzano J, Sala J, Sandel D, Sánchez M, Sánchez M, Sánchez P, Santamaría I, Sanz F, Serrano A, Somoza M, Tabernero E, Trujillo E, Valencia E, Valiño P, Vargas A, Vidal I, Vidal R, Villanueva M, Villar A, Vizcaya M, Zabaleta M, Zubillaga G. Factors Associated With Extrapulmonary Tuberculosis in Spain and Its Distribution in Immigrant Population. Open Respiratory Archives 2020. [DOI: 10.1016/j.opresp.2020.04.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
|
19
|
Serrano A, Wyn H, Dupont L, Villa-Gomez DK, Yermán L. Self-sustaining treatment as a novel alternative for the stabilization of anaerobic digestate. J Environ Manage 2020; 264:110544. [PMID: 32250925 DOI: 10.1016/j.jenvman.2020.110544] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/13/2019] [Revised: 03/28/2020] [Accepted: 03/29/2020] [Indexed: 06/11/2023]
Abstract
Self-sustaining smouldering combustion (SSS) is a technology based on the flameless oxidation of an organic substrate and limited by the rate at which oxygen is diffused to the surface of the substrate. This work aims to evaluate the SSS combustion as a treatment process for the stabilization of anaerobic digestate, determining the limits of operational conditions, (moisture content (MC), air flux) that allow for a self-sustaining process. Maximum possible MC was found at 82 wt% with Darcy air flux of 50 cm/s. The digestate destruction rate (kg/(h·m2), and the addition of sand as an inert solid, to enhance the oxygen diffusion, were also investigated. A sand/substrate mass ratio of 1 allowed for SSS at 85 wt% MC, but decreased the digestate destruction rate. The average composition of the emitted gases showed ca. 25% CO and 10% H2, whereas the analysis of the ashes showed almost complete digestate inertization.
Collapse
Affiliation(s)
- A Serrano
- School of Civil Engineering, The University of Queensland, Brisbane, 4072, Australia; Instituto de Grasa, Spanish National Research Council (CSIC), Ctra. de Utrera, km. 1, Seville, Spain
| | - H Wyn
- School of Civil Engineering, The University of Queensland, Brisbane, 4072, Australia
| | - L Dupont
- Département Génie Énergétique et Environnement, INSA, 69100, Villeurbanne, France
| | - D K Villa-Gomez
- School of Civil Engineering, The University of Queensland, Brisbane, 4072, Australia
| | - L Yermán
- School of Civil Engineering, The University of Queensland, Brisbane, 4072, Australia.
| |
Collapse
|
20
|
Sanchez-Marin L, Gavito AL, Decara J, Pastor A, Castilla-Ortega E, Suarez J, de la Torre R, Pavon FJ, Rodriguez de Fonseca F, Serrano A. Impact of intermittent voluntary ethanol consumption during adolescence on the expression of endocannabinoid system and neuroinflammatory mediators. Eur Neuropsychopharmacol 2020; 33:126-138. [PMID: 32057593 DOI: 10.1016/j.euroneuro.2020.01.012] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/08/2019] [Revised: 01/09/2020] [Accepted: 01/22/2020] [Indexed: 01/14/2023]
Abstract
The adolescent brain displays high vulnerability to the deleterious effects of ethanol, including greater risk of developing alcohol use disorder later in life. Here, we characterized the gene expression of the endocannabinoid system (ECS) and relevant signaling systems associated with neuroinflammation and emotional behaviors in the brain of young adult control and ethanol-exposed (EtOH) rats. We measured mRNA levels of candidate genes using quantitative real time PCR in the medial prefrontal cortex (mPFC), amygdala and hippocampus. EtOH rats were generated by maintenance on an intermittent and voluntary ethanol consumption during adolescence using the two-bottle choice paradigm (4 days/week for 4 weeks) followed by 2 week-withdrawal, a time-point of withdrawal with no physical symptoms. Mean differences and effect sizes were calculated using t-test and Cohen's d values. In the mPFC and hippocampus, EtOH rats had significantly higher mRNA expression of endocannabinoid-signaling (mPFC: Ppara, Dagla, Daglb and Napepld; and hippocampus: Cnr2, Dagla and Mgll) and neuroinflammation-associated genes (mPFC: Gfap; and hippocampus: Aif1) than in controls. Moreover, EtOH rats had significantly higher mRNA expression of neuropeptide Y receptor genes (Npy1r, Npy2r and Npy5r) in the hippocampus. Finally, EtOH rats also displayed higher plasma endocannabinoid levels than controls. In conclusion, these results suggest that adolescent ethanol exposure can lead to long-term alterations in the gene expression of the ECS and other signaling systems involved in neuroinflammation and regulation of emotional behaviors in key brain areas for the development of addiction.
Collapse
Affiliation(s)
- L Sanchez-Marin
- Unidad Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Avda. Carlos Haya 82, Sótano, Málaga 29010, Spain
| | - A L Gavito
- Unidad Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Avda. Carlos Haya 82, Sótano, Málaga 29010, Spain
| | - J Decara
- Unidad Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Avda. Carlos Haya 82, Sótano, Málaga 29010, Spain
| | - A Pastor
- Programa de Neurociencias, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain
| | - E Castilla-Ortega
- Unidad Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Avda. Carlos Haya 82, Sótano, Málaga 29010, Spain
| | - J Suarez
- Unidad Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Avda. Carlos Haya 82, Sótano, Málaga 29010, Spain
| | - R de la Torre
- Programa de Neurociencias, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain
| | - F J Pavon
- Unidad Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Avda. Carlos Haya 82, Sótano, Málaga 29010, Spain; Unidad Gestión Clínica del Corazón, IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain
| | - F Rodriguez de Fonseca
- Unidad Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Avda. Carlos Haya 82, Sótano, Málaga 29010, Spain.
| | - A Serrano
- Unidad Gestión Clínica de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Avda. Carlos Haya 82, Sótano, Málaga 29010, Spain.
| |
Collapse
|
21
|
Lalueza A, Ayuso B, Arrieta E, Trujillo H, Folgueira D, Cueto C, Serrano A, Laureiro J, Arévalo-Cañas C, Castillo C, Díaz-Pedroche C, Lumbreras C. Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection. Clin Microbiol Infect 2020; 26:1557.e9-1557.e15. [PMID: 32120038 DOI: 10.1016/j.cmi.2020.02.018] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2019] [Revised: 02/05/2020] [Accepted: 02/14/2020] [Indexed: 01/04/2023]
Abstract
OBJECTIVES There is increasing evidence that ferritin is a key marker of macrophage activation, but its potential role in influenza infection remains unexplored. Our aim was to assess whether hyperferritinaemia (ferritin ≥500 ng/mL) could be a marker of poor prognosis in hospitalized patients with confirmed influenza A infection. METHODS We prospectively recruited all hospitalized adult patients who tested positive for the influenza A rRT-PCR assay performed on respiratory samples in two consecutive influenza periods (2016-17 and 2017-18). Poor outcome was defined as the presence of at least one of the following: respiratory failure, admission to the intensive care unit, or in-hospital mortality. RESULTS Among 494 patients, 68 (14%) developed poor outcomes; 112 patients (23%) had hyperferritinaemia (39/68, 57% in the poor-outcome group versus 73/426, 17% in the remaining patients, p < 0.0001). Median serum ferritin levels were significantly higher in the subgroup of patients with poor outcomes (609 ng/mL, range 231-967 versus 217 ng/mL, range 140-394, p < 0.0001). In multivariate analysis, hyperferritinaemia was associated with a five-fold increase in the odds ratio of developing poor outcome. After adjusting for classic influenza risk factors, ferritin remained as a significant predictive factor in all exploratory models. Ferritin levels had a good discriminative capacity with an area under the ROC curve of 0.72 (95% confidence interval (CI) 0.65-0.8, p < 0.001) and an overall diagnostic accuracy for predicting poor outcome of 79.3% (95%CI 75.4-82.7%). CONCLUSIONS Serum ferritin may discriminate a subgroup of patients with influenza infection who have a higher risk of developing a poor outcome.
Collapse
Affiliation(s)
- A Lalueza
- Department of Internal Medicine, University Hospital 12 de Octubre, Madrid, Spain; Department of Medicine, School of Medicine, Complutense University, Madrid, Spain; Research Institute of Hospital 12 de Octubre (i+12), Madrid, Spain.
| | - B Ayuso
- Department of Internal Medicine, University Hospital 12 de Octubre, Madrid, Spain
| | - E Arrieta
- Department of Internal Medicine, University Hospital 12 de Octubre, Madrid, Spain
| | - H Trujillo
- Department of Internal Medicine, University Hospital 12 de Octubre, Madrid, Spain
| | - D Folgueira
- Research Institute of Hospital 12 de Octubre (i+12), Madrid, Spain; Department of Microbiology, University Hospital 12 de Octubre, Madrid, Spain; Department of Microbiology, School of Medicine, Complutense University, Madrid, Spain
| | - C Cueto
- Department of Biochemistry, University Hospital 12 de Octubre, Madrid, Spain
| | - A Serrano
- Research Institute of Hospital 12 de Octubre (i+12), Madrid, Spain; Department of Immunology, University Hospital 12 de Octubre, Madrid, Spain
| | - J Laureiro
- Department of Internal Medicine, University Hospital 12 de Octubre, Madrid, Spain
| | - C Arévalo-Cañas
- Department of Internal Medicine, University Hospital 12 de Octubre, Madrid, Spain
| | - C Castillo
- Department of Internal Medicine, University Hospital 12 de Octubre, Madrid, Spain
| | - C Díaz-Pedroche
- Department of Internal Medicine, University Hospital 12 de Octubre, Madrid, Spain; Department of Medicine, School of Medicine, Complutense University, Madrid, Spain
| | - C Lumbreras
- Department of Internal Medicine, University Hospital 12 de Octubre, Madrid, Spain; Department of Medicine, School of Medicine, Complutense University, Madrid, Spain; Research Institute of Hospital 12 de Octubre (i+12), Madrid, Spain; Infectious Diseases Unit, University Hospital 12 de Octubre, Madrid, Spain
| | | |
Collapse
|
22
|
González-Tallada A, Paniagua-Iglesias P, Font Gual A, Vives M, Serrano A, de Nadal M. Dabigatran in patients with myocardial injury after non-cardiac surgery. Report on the MANAGE Trial. ACTA ACUST UNITED AC 2019; 66:455-458. [PMID: 31629536 DOI: 10.1016/j.redar.2019.07.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2019] [Accepted: 07/19/2019] [Indexed: 11/30/2022]
Affiliation(s)
- A González-Tallada
- Departamento de Anestesiología y Reanimación, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España
| | - P Paniagua-Iglesias
- Departamento de Anestesiología y Reanimación, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - A Font Gual
- Departamento de Anestesiología y Reanimación, Hospital de la Santa Creu i Sant Pau, Barcelona, España
| | - M Vives
- Departamento de Anestesiología y Reanimación, Hospital Universitari de Girona Dr. J. Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, España
| | - A Serrano
- Departamento de Anestesiología y Reanimación, Hospital Ramón y Cajal, Madrid, España
| | - M de Nadal
- Departamento de Anestesiología y Reanimación, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España.
| |
Collapse
|
23
|
Serrano A, Apolloni S, Rossi S, Lattante S, Sabatelli M, Peric M, Andjus P, Michetti F, Carrì MT, Cozzolino M, D'Ambrosi N. The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis. Cells 2019; 8:cells8101261. [PMID: 31623154 PMCID: PMC6829868 DOI: 10.3390/cells8101261] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2019] [Revised: 10/11/2019] [Accepted: 10/14/2019] [Indexed: 02/07/2023] Open
Abstract
S100A4, belonging to a large multifunctional S100 protein family, is a Ca2+-binding protein with a significant role in stimulating the motility of cancer and immune cells, as well as in promoting pro-inflammatory properties in different cell types. In the CNS, there is limited information concerning S100A4 presence and function. In this study, we analyzed the expression of S100A4 and the effect of the S100A4 transcriptional inhibitor niclosamide in murine activated primary microglia. We found that S100A4 was strongly up-regulated in reactive microglia and that niclosamide prevented NADPH oxidase 2, mTOR (mammalian target of rapamycin), and NF-κB (nuclear factor-kappa B) increase, cytoskeletal rearrangements, migration, and phagocytosis. Furthermore, we found that S100A4 was significantly up-regulated in astrocytes and microglia in the spinal cord of a transgenic rat SOD1-G93A model of amyotrophic lateral sclerosis. Finally, we demonstrated the increased expression of S100A4 also in fibroblasts derived from amyotrophic lateral sclerosis (ALS) patients carrying SOD1 pathogenic variants. These results ascribe S100A4 as a marker of microglial reactivity, suggesting the contribution of S100A4-regulated pathways to neuroinflammation, and identify niclosamide as a possible drug in the control and attenuation of reactive phenotypes of microglia, thus opening the way to further investigation for a new application in neurodegenerative conditions.
Collapse
Affiliation(s)
- Alessia Serrano
- Institute of Anatomy and Cell Biology, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
| | - Savina Apolloni
- Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.
| | - Simona Rossi
- Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.
- Institute of Translational Pharmacology, CNR, 00133 Rome, Italy.
| | - Serena Lattante
- Unità Operativa Complessa di Genetica Medica, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
- Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
| | - Mario Sabatelli
- Unità Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
- Centro Clinico NEMO, 00168 Rome, Italy.
- Istituto di Neurologia, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
| | - Mina Peric
- Institute of Physiology and Biochemistry "Ivan Djaja", Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia.
| | - Pavle Andjus
- Institute of Physiology and Biochemistry "Ivan Djaja", Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia.
| | - Fabrizio Michetti
- Institute of Anatomy and Cell Biology, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
| | - Maria Teresa Carrì
- Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.
| | - Mauro Cozzolino
- Institute of Translational Pharmacology, CNR, 00133 Rome, Italy.
| | - Nadia D'Ambrosi
- Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.
| |
Collapse
|
24
|
Fernández-Tomé B, Díaz-Güemes I, Enciso Sanz S, Moreno Naranjo B, Correa L, Sánchez-Hurtado M, Usón J, Bachiller J, Serrano A, Sánchez-Margallo F. Validation of a new artificial model for simulated training of a laparoscopic vesicourethral anastomosis. Actas Urol Esp 2019; 43:348-354. [PMID: 31128874 DOI: 10.1016/j.acuro.2019.03.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2018] [Revised: 01/17/2019] [Accepted: 03/19/2019] [Indexed: 12/15/2022]
Abstract
OBJECTIVE The aim of this study is to prove the effectiveness of a low cost, artificial model for training of a laparoscopic urethrovesical anastomosis. MATERIALS AND METHODS This study included urologists who attended specialised courses on laparoscopic radical prostatectomy (LRP) held during the period 2015 to 2017. They were divided into 2 groups according to their previous experience in laparoscopic surgery. The tasks performed on the artificial simulator were prostate resection, "task 1", and urethrovesical anastomosis, "task 2". Once these exercises were completed, the study participants filled in an anonymous questionnaire regarding their demographic data and experience level in laparoscopic surgery (LS). In addition, they gave their opinions about the didactic capacity of the artificial organ and evaluated its usefulness as a tool for LRP training. To demonstrate face and content validity, the participants judged the texture, consistency, morphology and evaluated its similarity to the real organ. The assessment was made with a five-point Likert scale. RESULTS The students were divided into 2groups: 10 experts (Group E) and 12 novices (Group N). The only significant difference between the scores of novices and experts was regarding the inclusion of this tool in the training programs (Group E=5 points versus group N=4.4±0.59, P=.024). The experts' group rated all the items with higher scores than the novices' one. Regarding the general assessment of the simulation model, the novice participants gave an average score of 8.00±0.91 points out of 10, while the experts' group granted higher scores of 9.4±0,51. CONCLUSION This artificial model has shown to have an elevated face, content and construct validity, as well being an optimal didactic tool for training in the techniques of prostate resection and laparoscopic urethrovesical anastomosis.
Collapse
|
25
|
Lucas-Abellán C, Pérez-Abril M, Castillo J, Serrano A, Mercader M, Fortea M, Gabaldón J, Núñez-Delicado E. Effect of temperature, pH, β- and HP-β-cds on the solubility and stability of flavanones: Naringenin and hesperetin. Lebensm Wiss Technol 2019. [DOI: 10.1016/j.lwt.2019.03.059] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
26
|
López-Sánchez J, Serrano A, Del Campo A, Abuín M, Salas-Colera E, Muñoz-Noval A, Castro GR, de la Figuera J, Marco JF, Marín P, Carmona N, Rodríguez de la Fuente O. Self-assembly of iron oxide precursor micelles driven by magnetic stirring time in sol-gel coatings. RSC Adv 2019; 9:17571-17580. [PMID: 35520560 PMCID: PMC9064545 DOI: 10.1039/c9ra03283e] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2019] [Accepted: 05/24/2019] [Indexed: 11/21/2022] Open
Abstract
The purpose of this work is to fabricate self-assembled microstructures by the sol–gel method and study the morphological, structural and compositional dependence of ε-Fe2O3 nanoparticles embedded in silica when glycerol (GLY) and cetyl-trimethylammonium bromide (CTAB) are added as steric agents simultaneously. The combined action of a polyalcohol and a surfactant significantly modifies the morphology of the sample giving rise to a different microstructure in each of the studied cases (1, 3 and 7 days of magnetic stirring time). This is due to the fact that the addition of these two compounds leads to a considerable increase in gelation time as GLY can interact with the alkoxide group on the surface of the iron oxide precursor micelle and/or be incorporated into the hydrophilic chains of CTAB. This last effect causes the iron oxide precursor micelles to be interconnected forming aggregates whose size and structure depend on the magnetic stirring time of the sol–gel synthetic route. In this paper, crystalline structure, composition, purity and morphology of the sol–gel coatings densified at 960 °C are examined. Emphasis is placed on the nominal percentage of the different iron oxides found in the samples and on the morphological and structural differences. This work implies the possibility of patterning ε-Fe2O3 nanoparticles in coatings and controlling their purity by an easy one-pot sol–gel method. Sol–gel synthesis of self-assembled iron oxide precursor micelles.![]()
Collapse
Affiliation(s)
- J López-Sánchez
- Instituto de Magnetismo Aplicado, UCM-CSIC-ADIF 28230 Madrid Spain
| | - A Serrano
- Instituto de Cerámica y Vidrio, ICV-CSIC 28049 Madrid Spain.,SpLine, Spanish CRG BM25 Beamline, ESRF-The European Synchrotron 38000 Grenoble France.,Instituto de Ciencia de Materiales de Madrid, ICMM-CSIC 28049 Madrid Spain
| | - A Del Campo
- Instituto de Cerámica y Vidrio, ICV-CSIC 28049 Madrid Spain
| | - M Abuín
- Instituto de Sistemas Optoelectrónicos y Microtecnología, ISOM-UPM 28040 Madrid Spain
| | - E Salas-Colera
- SpLine, Spanish CRG BM25 Beamline, ESRF-The European Synchrotron 38000 Grenoble France.,Instituto de Ciencia de Materiales de Madrid, ICMM-CSIC 28049 Madrid Spain
| | - A Muñoz-Noval
- SpLine, Spanish CRG BM25 Beamline, ESRF-The European Synchrotron 38000 Grenoble France.,Instituto de Ciencia de Materiales de Madrid, ICMM-CSIC 28049 Madrid Spain.,Departamento de Física de Materiales, Universidad Complutense de Madrid (UCM) 28040 Madrid Spain
| | - G R Castro
- SpLine, Spanish CRG BM25 Beamline, ESRF-The European Synchrotron 38000 Grenoble France.,Instituto de Ciencia de Materiales de Madrid, ICMM-CSIC 28049 Madrid Spain
| | - J de la Figuera
- Instituto de Química Física "Rocasolano", IQFR-CSIC 28006 Madrid Spain
| | - J F Marco
- Instituto de Química Física "Rocasolano", IQFR-CSIC 28006 Madrid Spain
| | - P Marín
- Instituto de Magnetismo Aplicado, UCM-CSIC-ADIF 28230 Madrid Spain .,Departamento de Física de Materiales, Universidad Complutense de Madrid (UCM) 28040 Madrid Spain
| | - N Carmona
- Instituto de Magnetismo Aplicado, UCM-CSIC-ADIF 28230 Madrid Spain .,Departamento de Física de Materiales, Universidad Complutense de Madrid (UCM) 28040 Madrid Spain
| | - O Rodríguez de la Fuente
- Instituto de Magnetismo Aplicado, UCM-CSIC-ADIF 28230 Madrid Spain .,Departamento de Física de Materiales, Universidad Complutense de Madrid (UCM) 28040 Madrid Spain
| |
Collapse
|
27
|
Zapata Martínez O, Serrano A, Aguilera Flores MM, Villa-Gómez DK. Rabbit manure as a potential inoculum for anaerobic digestion. J Environ Sci Health A Tox Hazard Subst Environ Eng 2019; 54:943-950. [PMID: 31057058 DOI: 10.1080/10934529.2019.1610293] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 04/16/2019] [Accepted: 04/17/2019] [Indexed: 06/09/2023]
Abstract
The potential of using rabbit manure as inoculum for biogas production was evaluated through batch assays using bean straw as substrate. The microbial diversity in the rabbit manure included lignin-degrading bacteria (classes Bacteroidia, Bacilli and Clostridia) as well as key acetoclastic (Matheanosarcina and Methanosaeta), and hydrogenotrophic (Methanobacterium, Methanolinea, and Methanovebribacter) archaea. The effects of particle size, substrate to inoculum ratio (S/X) and pH adjustment were studied to improve the inoculum activity. The adjustment of the pH entailed the highest improvement in methane production (515%) and rate (164%). However, high S/X, (3-4), resulted in the acidification of the processes, denoting an imbalance between hydrolytic bacteria and methanogenic archaea in the rabbit manure. This confirmed that the use of rabbit manure as inoculum could sustain anaerobic digestion from agricultural residues, although a proper enrichment and adaptation is necessary to ensure an appropriate methane production.
Collapse
Affiliation(s)
- O Zapata Martínez
- a Unidad Profesional Interdisciplinaria De Ingeniería Campus Zacatecas, Instituto Politécnico Nacional , Zacatecas , México
| | - A Serrano
- b School of Civil Engineering , The University of Queensland , St Lucia , QLD , Australia
| | - M M Aguilera Flores
- a Unidad Profesional Interdisciplinaria De Ingeniería Campus Zacatecas, Instituto Politécnico Nacional , Zacatecas , México
| | - D K Villa-Gómez
- b School of Civil Engineering , The University of Queensland , St Lucia , QLD , Australia
| |
Collapse
|
28
|
Merino D, Weber TS, Serrano A, Vaillant F, Liu K, Pal B, Di Stefano L, Schreuder J, Lin D, Chen Y, Asselin-Labat ML, Schumacher TN, Cameron D, Smyth GK, Papenfuss AT, Lindeman GJ, Visvader JE, Naik SH. Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer. Nat Commun 2019; 10:1945. [PMID: 31019194 PMCID: PMC6482144 DOI: 10.1038/s41467-019-09916-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Affiliation(s)
- D Merino
- ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. .,Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia. .,Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia. .,School of Cancer Medicine, La Trobe University, Bundoora, VIC, 3086, Australia.
| | - T S Weber
- Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia.,Molecular Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia
| | - A Serrano
- ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.,Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia.,Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia
| | - F Vaillant
- ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.,Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia
| | - K Liu
- ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.,Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia
| | - B Pal
- ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.,Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia
| | - L Di Stefano
- Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia
| | - J Schreuder
- Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia.,Molecular Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.,Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia
| | - D Lin
- Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia.,Molecular Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.,Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia
| | - Y Chen
- Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia.,Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia
| | - M L Asselin-Labat
- ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.,Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia
| | - T N Schumacher
- Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands
| | - D Cameron
- Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia
| | - G K Smyth
- Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.,School of Mathematics and Statistics, The University of Melbourne, Melbourne, VIC, 3010, Australia
| | - A T Papenfuss
- Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia.,Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.,School of Mathematics and Statistics, The University of Melbourne, Melbourne, VIC, 3010, Australia.,Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.,Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, 3010, Australia
| | - G J Lindeman
- ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.,Department of Medical Oncology, The Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.,Department of Medicine, The University of Melbourne, Melbourne, VIC, 3010, Australia.,Parkville Familial Cancer Centre, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, VIC, 3050, Australia
| | - J E Visvader
- ACRF Stem Cells and Cancer Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. .,Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia.
| | - S H Naik
- Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia. .,Molecular Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. .,Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
| |
Collapse
|
29
|
Wyman V, Serrano A, Borja R, Jiménez A, Carvajal A, Lenz M, Bartacek J, Fermoso FG. Effects of barium on the pathways of anaerobic digestion. J Environ Manage 2019; 232:397-403. [PMID: 30500703 DOI: 10.1016/j.jenvman.2018.11.065] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/07/2018] [Revised: 11/13/2018] [Accepted: 11/16/2018] [Indexed: 06/09/2023]
Abstract
The sufficient presence of trace elements (TE) is essential for anaerobic digestion. Barium (Ba) is considered a non-essential trace element that can be collaterally added to digesters as part of low-cost trace element sources or because of its presence in some feedstocks, such as crude glycerol. In the present study, the impact of Ba supplementation (2-2000 mg/L) on each stage of the anaerobic digestion (AD) process was evaluated using pure substrates (i.e., cellulose, glucose, a mixture of volatile fatty acids, sodium acetate and hydrogen) as well as a complex substrate (i.e., dried green fodder). Hydrolytic activity was affected at dosages higher than 200 mg Ba/L, whereas cellulose degradation was completely inhibited at 2000 mg Ba/L. The negative effects of the addition of Ba to methane production were observed only in the hydrolytic activity, and no effects were detected at any barium dosage in the subsequent anaerobic steps. Because Ba does not have a reported role as a cofactor of enzymes, this response could have been due to a direct inhibitory effect, a variation in the bioavailability of other trace elements, or even the availability of CO2/SO4 through precipitation as Ba-carbonates and sulphates. The results showed that the addition of Ba modified the chemical equilibrium of the studied system by varying the soluble concentration of some TEs and therefore their bioavailability. The highest variation was detected in the soluble concentration of zinc, which increased as the amount of Ba increased. Although little research has shown that Ba has some utility in anaerobic processes, its addition must be carefully monitored to avoid an undesirable modification of the chemical equilibrium in the system.
Collapse
Affiliation(s)
- V Wyman
- Universidad Técnica Federico Santa María, Avenida Vicuña Mackenna 3939, San Joaquín, Santiago, Chile; Universidad Pablo de Olavide, Carretera de Utrera, 1, 41013, Seville, Spain
| | - A Serrano
- Instituto de la Grasa (CSIC), Seville, Spain; School of Civil Engineering, The University of Queensland, Ed. 49, Campus St Lucia, 4067, Brisbane, Australia.
| | - R Borja
- Instituto de la Grasa (CSIC), Seville, Spain
| | - A Jiménez
- Universidad Pablo de Olavide, Carretera de Utrera, 1, 41013, Seville, Spain
| | - A Carvajal
- Universidad Técnica Federico Santa María, Avenida Vicuña Mackenna 3939, San Joaquín, Santiago, Chile
| | - M Lenz
- Institute for Ecopreneurship, School of Life Sciences, University of Applied Sciences and Arts Northwestern Switzerland, Switzerland; Sub-Department of Environmental Technology, Wageningen University, 6700 AA, Wageningen, the Netherlands
| | - J Bartacek
- University of Chemistry and Technology Prague, Czech Republic
| | - F G Fermoso
- Instituto de la Grasa (CSIC), Seville, Spain
| |
Collapse
|
30
|
Michetti F, D'Ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E, Corvino V, Geloso MC. The S100B story: from biomarker to active factor in neural injury. J Neurochem 2018; 148:168-187. [DOI: 10.1111/jnc.14574] [Citation(s) in RCA: 128] [Impact Index Per Article: 21.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2018] [Revised: 07/19/2018] [Accepted: 08/15/2018] [Indexed: 02/06/2023]
Affiliation(s)
- Fabrizio Michetti
- Institute of Anatomy and Cell Biology; Università Cattolica del Sacro Cuore; Rome Italy
- IRCCS San Raffaele Scientific Institute; Università Vita-Salute San Raffaele; Milan Italy
| | - Nadia D'Ambrosi
- Department of Biology; Università degli Studi di Roma Tor Vergata; Rome Italy
| | - Amelia Toesca
- Institute of Anatomy and Cell Biology; Università Cattolica del Sacro Cuore; Rome Italy
| | | | - Alessia Serrano
- Institute of Anatomy and Cell Biology; Università Cattolica del Sacro Cuore; Rome Italy
| | - Elisa Marchese
- Institute of Anatomy and Cell Biology; Università Cattolica del Sacro Cuore; Rome Italy
| | - Valentina Corvino
- Institute of Anatomy and Cell Biology; Università Cattolica del Sacro Cuore; Rome Italy
| | - Maria Concetta Geloso
- Institute of Anatomy and Cell Biology; Università Cattolica del Sacro Cuore; Rome Italy
| |
Collapse
|
31
|
Infantino M, Shovman O, Pérez D, Grossi V, Manfredi M, Benucci M, Damiani A, Gilburd B, Azoulay D, Serrano A, Shoenfeld Y. A better definition of the anti-DFS70 antibody screening by IIF methods. J Immunol Methods 2018; 461:110-116. [DOI: 10.1016/j.jim.2018.07.001] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2018] [Revised: 07/05/2018] [Accepted: 07/05/2018] [Indexed: 11/15/2022]
|
32
|
Salvatori I, Ferri A, Scaricamazza S, Giovannelli I, Serrano A, Rossi S, D'Ambrosi N, Cozzolino M, Giulio AD, Moreno S, Valle C, Carrì MT. Differential toxicity of TAR DNA-binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells. J Neurochem 2018; 146:585-597. [PMID: 29779213 DOI: 10.1111/jnc.14465] [Citation(s) in RCA: 37] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2018] [Revised: 03/20/2018] [Accepted: 04/23/2018] [Indexed: 12/13/2022]
Abstract
TAR DNA-binding protein 43 (TDP-43) is an RNA-binding protein and a major component of protein aggregates found in amyotrophic lateral sclerosis and several other neurodegenerative diseases. TDP-43 exists as a full-length protein and as two shorter forms of 25 and 35 kDa. Full-length mutant TDP-43s found in amyotrophic lateral sclerosis patients re-localize from the nucleus to the cytoplasm and in part to mitochondria, where they exert a toxic role associated with neurodegeneration. However, induction of mitochondrial damage by TDP-43 fragments is yet to be clarified. In this work, we show that the mitochondrial 35 kDa truncated form of TDP-43 is restricted to the intermembrane space, while the full-length forms also localize in the mitochondrial matrix in cultured neuronal NSC-34 cells. Interestingly, the full-length forms clearly affect mitochondrial metabolism and morphology, possibly via their ability to inhibit the expression of Complex I subunits encoded by the mitochondrial-transcribed mRNAs, while the 35 kDa form does not. In the light of the known differential contribution of the full-length and short isoforms to generate toxic aggregates, we propose that the presence of full-length TDP-43s in the matrix is a primary cause of mitochondrial damage. This in turn may cause oxidative stress inducing toxic oligomers formation, in which short TDP-43 forms play a major role.
Collapse
Affiliation(s)
| | - Alberto Ferri
- Fondazione Santa Lucia IRCCS, c/o CERC, Rome, Italy.,Institute for Cell Biology and Neurobiology, CNR, c/o CERC, Rome, Italy
| | - Silvia Scaricamazza
- Fondazione Santa Lucia IRCCS, c/o CERC, Rome, Italy.,Department of Biology, University of Rome Tor Vergata, Rome, Italy
| | | | - Alessia Serrano
- Institute of Anatomy and Cell Biology, Università Cattolica del Sacro Cuore, Rome, Italy
| | - Simona Rossi
- Institute of Translational Pharmacology, CNR, Rome, Italy
| | - Nadia D'Ambrosi
- Department of Biology, University of Rome Tor Vergata, Rome, Italy
| | - Mauro Cozzolino
- Fondazione Santa Lucia IRCCS, c/o CERC, Rome, Italy.,Institute of Translational Pharmacology, CNR, Rome, Italy
| | | | - Sandra Moreno
- Department of Science, LIME, University Roma Tre, Rome, Italy
| | - Cristiana Valle
- Fondazione Santa Lucia IRCCS, c/o CERC, Rome, Italy.,Institute for Cell Biology and Neurobiology, CNR, c/o CERC, Rome, Italy
| | - Maria Teresa Carrì
- Fondazione Santa Lucia IRCCS, c/o CERC, Rome, Italy.,Department of Biology, University of Rome Tor Vergata, Rome, Italy
| |
Collapse
|
33
|
Barrio P, Crespillo M, Luque J, Aler M, Baeza-Richer C, Baldassarri L, Carnevali E, Coufalova P, Flores I, García O, García M, González R, Hernández A, Inglés V, Luque G, Mosquera-Miguel A, Pedrosa S, Pontes M, Porto M, Posada Y, Ramella M, Ribeiro T, Riego E, Sala A, Saragoni V, Serrano A, Vannelli S. GHEP-ISFG collaborative exercise on mixture profiles (GHEP-MIX06). Reporting conclusions: Results and evaluation. Forensic Sci Int Genet 2018; 35:156-163. [DOI: 10.1016/j.fsigen.2018.05.005] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2017] [Revised: 04/30/2018] [Accepted: 05/13/2018] [Indexed: 11/25/2022]
|
34
|
Gómez CJ, Sánchez N, Mendoza A, Rubio M, Serrano A, Aguiló M. Impact of the pharmaceutical smoking cessation service on the Spanish community pharmacy. Tob Prev Cessat 2018. [DOI: 10.18332/tpc/90656] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
35
|
Decara J, Rivera P, Arrabal S, Vargas A, Serrano A, Pavón FJ, Dieguez C, Nogueiras R, Rodríguez de Fonseca F, Suárez J. Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats. Acta Physiol (Oxf) 2018; 222:e13008. [PMID: 29193738 DOI: 10.1111/apha.13008] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2017] [Revised: 11/13/2017] [Accepted: 11/23/2017] [Indexed: 12/19/2022]
Abstract
AIM To explore the cooperation of GLP-1 receptor and β3-adrenergic receptor (β3-AR)-mediated signalling in the control of fat mass/feeding behaviour by studying the effects of a combined therapy composed of the GLP-1R agonist liraglutide and the β3-AR agonist CL316243. METHODS The study included the analysis of key mechanisms regulating lipid/cholesterol metabolism, and thermogenesis in brown (BAT) and epididymal white (eWAT) adipose tissues, abdominal muscle and liver of male rats. RESULTS CL316243 (1 mg kg-1 ) and liraglutide (100 μg kg-1 ) co-administration over 6 days potentiated an overall negative energy balance (reduction in food intake, body weight gain, fat/non-fat mass ratio, liver fat content, and circulating levels of non-essential fatty acids, triglycerides, very low-density lipoprotein-cholesterol and leptin). These effects were accompanied by increased plasma levels of insulin and IL6. We also observed increased gene expression of uncoupling proteins regulating thermogenesis in BAT/eWAT (Ucp1) and muscle (Ucp2/3). Expression of transcription factor and enzymes involved either in de novo lipogenesis (Chrebp, Acaca, Fasn, Scd1, Insig1, Srebp1) or in fatty acid β-oxidation (Cpt1b) was enhanced in eWAT and/or muscle but decreased in BAT. Pparα and Pparγ, essentials in lipid flux/storage, were decreased in BAT/eWAT but increased in the muscle and liver. Cholesterol synthesis regulators (Insig2, Srebp2, Hmgcr) were particularly over-expressed in muscle. These GLP-1R/β3-AR-induced metabolic effects were associated with the downregulation of cAMP-dependent signalling pathways (PKA/AKT/AMPK). CONCLUSION Combined activation of GLP-1 and β3-ARs potentiate changes in peripheral pathways regulating lipid/cholesterol metabolism in a tissue-specific manner that favours a switch in energy availability/expenditure and may be useful for obesity treatment.
Collapse
Affiliation(s)
- J. Decara
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - P. Rivera
- Department of Endocrinology; Fundación Investigación Biomédica del Hospital Infantil Universitario Niño Jesús; Madrid Spain
| | - S. Arrabal
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - A. Vargas
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - A. Serrano
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - F. J. Pavón
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - C. Dieguez
- Department of Physiology; School of Medicine-CIMUS; University of Santiago De Compostela-Instituto De Investigación Sanitaria; Santiago De Compostela Spain
- CIBER OBN; Instituto de Salud Carlos III; Madrid Spain
| | - R. Nogueiras
- Department of Physiology; School of Medicine-CIMUS; University of Santiago De Compostela-Instituto De Investigación Sanitaria; Santiago De Compostela Spain
- CIBER OBN; Instituto de Salud Carlos III; Madrid Spain
| | - F. Rodríguez de Fonseca
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
| | - J. Suárez
- Instituto de Investigación Biomédica de Málaga (IBIMA); UGC Salud Mental; Universidad de Málaga, Hospital Universitario Regional de Málaga; Málaga Spain
- Departamento de Biología Celular; Genética y Fisiología; Facultad de Ciencias; IBIMA; Universidad de Málaga; Málaga Spain
| |
Collapse
|
36
|
Lynce F, Serrano A, Friedman S, Nahleh Z, Dutil J, Campos C, Ricker C, Rodriguez P, Duron Y, Isaacs C, Graves K. Abstract P6-10-05: UPTAKE study - Uptake of preventive surgeries among Latinas with BRCA1/2 mutations. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p6-10-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Germline testing for BRCA1/2 genes provides an opportunity to reduce mortality and morbidity by adopting appropriate risk reduction and screening options, in particular with risk-reducing bilateral salpingo-oophorectomy (BSO).There is a paucity of data on Latinas and prophylactic measures among BRCA1/2 carriers.Existing studies are limited either by the small number of Latinas, or limited to a specific geographic location.Factors related to decision making have also not been evaluated.
Methods: The UPTAKE study is an observational study of Latinas with germline BRCA1/2 mutations.Subjects were recruited nationally and, by telephone interviews, reported uptake of prophylactic surgeries (BSO, bilateral mastectomy in unaffected women, and contralateral mastectomy in carriers with breast cancer (BC)). Women with ovarian cancer were ineligible. All women had to have been informed that they carried a deleterious BRCA1/2 mutation at least 1 year prior to completing the interview. The objectives of this study are: 1)to examine the rate of uptake of prophylactic surgeries; 2)identify acculturation and attitudinal factors related to decisions made and 3)examine relationships between primary language, receipt of genetic counseling (GC) and in which language it was provided and uptake of prophylactic surgeries. We plan to enroll 100 participants.
Results: As of 6/11/2017, 86 telephone interviews have been conducted. We anticipate that all 100 interviews will be completed by July 2017. 51.2% (44/86) of participants completed the interview in Spanish. Our population was diverse in terms of country of origin: 50.0% (43/86) were born in the US, 22.1% (19/86) in Mexico, 11.6% (10/86) in Puerto Rico, 4.6% (4/86) in El Salvador, 3.5% (3/86) in Ecuador and 8.1% (7/86) in other countries of Latin America. 30% (26/86) of the participants reported an annual household income inferior to $50.000. Only 26.7% (23/86) of women reported having a graduate degree. Approximately one quarter of participants were unemployed at the time of study participation (26.7%, 23/86). 34.9% (30/86) were unaffected and 62.8% (54/86) were affected with BC. 73.3% (63/86) of participants reported having received formal GC, of which only 28.6% (18/63) was conducted in Spanish. 66.3% (57/86) of women opted to undergo BSO and 58.1% (50/86) underwent prophylactic mastectomy. Being born outside the US and currently working were associated with higher uptake of BSO. Multivariate analysis will be performed once all interviews have been completed.
Conclusions: To our knowledge this is the largest study that evaluates uptake of prophylactic measures in Latinas known to be BRCA1/2 carriers. Our study included a heterogeneous group of participants in terms of country of origin, income and level of education including English knowledge. It was conducted across various academic and community centers in the country. The uptake of prophylactic surgeries among Latinas with germline BRCA mutations seems to be slightly lower than what has been reported in non-Hispanic whites (71-74%) but higher than in African Americans (32-50%). Results and factors associated with decision making will be updated once the total number of participants is enrolled.
Citation Format: Lynce F, Serrano A, Friedman S, Nahleh Z, Dutil J, Campos C, Ricker C, Rodriguez P, Duron Y, Isaacs C, Graves K. UPTAKE study - Uptake of preventive surgeries among Latinas with BRCA1/2 mutations [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P6-10-05.
Collapse
Affiliation(s)
- F Lynce
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| | - A Serrano
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| | - S Friedman
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| | - Z Nahleh
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| | - J Dutil
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| | - C Campos
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| | - C Ricker
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| | - P Rodriguez
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| | - Y Duron
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| | - C Isaacs
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| | - K Graves
- Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Facing Our Risk of Cancer Empowered, Tampa, FL; Maroone Cancer Center, Cleveland Clinic Florida, Weston, FL; Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico; Nueva Vida, Alexandria, VA; USC Norris Comprehensive Cancer Center, Los Angeles, CA; US Oncology, Arlington, VA; Latinas Contra Cancer, San Jose, CA
| |
Collapse
|
37
|
Martins J, Neves J, Serrano A, Abecasis I, Albuquerque A, Freitas A, Nunes J, Charneca R. O porco Ribatejano: Renascimento de uma população autóctone? Primeiros dados de crescimento e de carcaça. ARCH ZOOTEC 2018. [DOI: 10.21071/az.v67isupplement.3588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
No âmbito do projeto TREASURE e com o objectivo de avaliar o desempenho produtivo do porco Ribatejano, resultante do cruzamento entre porcos Alentejanos (AL) e Bísaros (BI), 10 machos castrados de cada um dos genótipos AL, BI, ALxBI e BIxAL, foram estudados. Os animais foram criados em sistema tradicional e alimentados com rações comerciais ad libitum, tendo sido abatidos a ~65 kg de peso vivo (PV). Os dados obtidos mostraram que os suínos BI, ALxBI e BIxAL atingiram o peso de abate mais rapidamente (P
Collapse
|
38
|
Matos T, Hanzen T, Gutiérrez M, Malaquias P, De Paula A, Serrano A, De Souza J, Hass V, Loguercio A. Clinical evaluation of restorations in cervical lesions with copper-containing adhesive. Dent Mater 2018. [DOI: 10.1016/j.dental.2018.08.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
39
|
López-Sánchez J, Muñoz-Noval A, Castellano C, Serrano A, Del Campo A, Cabero M, Varela M, Abuín M, de la Figuera J, Marco JF, Castro GR, Rodríguez de la Fuente O, Carmona N. Origin of the magnetic transition at 100 K in ε-Fe 2O 3 nanoparticles studied by x-ray absorption fine structure spectroscopy. J Phys Condens Matter 2017; 29:485701. [PMID: 29116941 DOI: 10.1088/1361-648x/aa904b] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The current study unveils the structural origin of the magnetic transition of the ε-Fe2O3 polymorph from an incommensurate magnetic order to a collinear ferrimagnetic state at low temperature. The high crystallinity of the samples and the absence of other iron oxide polymorphs have allowed us to carry out temperature-dependent x-ray absorption fine structure spectroscopy experiments out. The deformation of the structure is followed by the Debye-Waller factor for each selected Fe-O and Fe-Fe sub-shell. For nanoparticle sizes between 7 and 15 nm, the structural distortions between the Fete and Fe-D1oc sites are localized in a temperature range before the magnetic transition starts. On the contrary, the inherent interaction between the other sub-shells (named Fe-O1,2 and Fe-Fe1) provokes cooperative magneto-structural changes in the same temperature range. This means that the Fete with Fe-D1oc polyhedron interaction seems to be uncoupled with temperature dealing with these nanoparticle sizes wherein the structural distortions are likely moderate due to surface effects.
Collapse
Affiliation(s)
- J López-Sánchez
- Departamento de Física de Materiales, Universidad Complutense de Madrid, 28040 Madrid, Spain. Unidad Asociada IQFR (CSIC)-UCM, 28040 Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Serrano A, Pinto-Ibieta F, Braga AFM, Jeison D, Borja R, Fermoso FG. Risks of using EDTA as an agent for trace metals dosing in anaerobic digestion of olive mill solid waste. Environ Technol 2017; 38:3137-3144. [PMID: 28151052 DOI: 10.1080/09593330.2017.1290149] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Low concentrations of trace elements in many organic wastes recommend their supplementation in order to avoid potential limitations. Different chelating agents have been used to ensure an adequate trace metal pool in the soluble fraction, by forming dissolved complexes. Ethylenediaminetetraacetic acid (EDTA) is probably the most common, although several negative effects could be associated with its usage. Biomethane potential tests were performed using Olive Mill Solid Waste as the substrate, supplementing different combinations of Fe, Co, Ni, Ba, always under the presence of EDTA. Results show that Ni and Co slightly recovered biodegradability. However, Ba supplementation resulted in worsening the methane yield coefficient in all cases. High concentration of EDTA led to decrease in the activity of anaerobic digestion. High availability of EDTA induces the capture of trace metals like Co or Ni, key trace metals for anaerobic biomass activity. While supplementing trace metals, the addition of Ba and/or EDTA must be carefully considered.
Collapse
Affiliation(s)
- A Serrano
- a Instituto de la Grasa (C.S.I.C.), Edificio 46 , Campus Universitario Pablo de Olavide , Sevilla , Spain
| | - F Pinto-Ibieta
- b Master of Engineering Sciences with Specialization in Biotechnology , Universidad de La Frontera , Temuco , Chile
- c Escuela de Procesos Industriales, Facultad de Ingeniería , Universidad Católica de Temuco , Temuco , Chile
| | - A F M Braga
- d Biological Processes Laboratory, Center for Research, Development and Innovation in Environmental Engineering, São Carlos School of Engineering (EESC) , University of São Paulo (USP) , São Carlos , Brazil
| | - D Jeison
- e Department of Chemical Engineering , Universidad de La Frontera , Temuco , Chile
| | - R Borja
- a Instituto de la Grasa (C.S.I.C.), Edificio 46 , Campus Universitario Pablo de Olavide , Sevilla , Spain
| | - F G Fermoso
- a Instituto de la Grasa (C.S.I.C.), Edificio 46 , Campus Universitario Pablo de Olavide , Sevilla , Spain
| |
Collapse
|
41
|
Pérez D, Tincani A, Serrano M, Shoenfeld Y, Serrano A. Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess. Lupus 2017; 27:177-178. [PMID: 29067871 DOI: 10.1177/0961203317738227] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
IgA anti-beta2-glycoprotein I (IgA-aB2GPI) antibodies are currently not included as a laboratory criterion of antiphospholipid syndrome (APS). In the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, (USA) in 2010, these antibodies were accepted as an APS laboratory criterion in patients who had clinical manifestations of APS but were negative for "consensus" antiphospholipid antibodies (aPL) (IgG and IgM isotypes). Consequently, individuals with thrombotic events who are negative for consensus aPL may be undiagnosed for APS. The most recent publications have confirmed that IgA-aB2GPI antibodies are a risk factor for thrombotic events. In this viewpoint, we propose that IgA-aB2GPI antibodies should be included as an APS consensus criterion and that we have to help Cinderella become a princess.
Collapse
Affiliation(s)
- D Pérez
- 1 Department of Immunology, 16473 Hospital Universitario 12 de Octubre , Madrid, Spain.,2 Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Aviv, Israel
| | - A Tincani
- 3 Rheumatology and Clinical Immunology Department, Spedali Civili of Brescia, Brescia, Italy
| | - M Serrano
- 1 Department of Immunology, 16473 Hospital Universitario 12 de Octubre , Madrid, Spain
| | - Y Shoenfeld
- 2 Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Aviv, Israel
| | - A Serrano
- 1 Department of Immunology, 16473 Hospital Universitario 12 de Octubre , Madrid, Spain
| |
Collapse
|
42
|
Ibanez-Rosello B, Bautista JA, Bonaque J, Perez-Calatayud J, Gonzalez-Sanchis A, Lopez-Torrecilla J, Brualla-Gonzalez L, Garcia-Hernandez T, Vicedo-Gonzalez A, Granero D, Serrano A, Borderia B, Solera C, Rosello J. Failure modes and effects analysis of total skin electron irradiation technique. Clin Transl Oncol 2017; 20:330-365. [PMID: 28779421 DOI: 10.1007/s12094-017-1721-3] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2017] [Accepted: 07/24/2017] [Indexed: 11/26/2022]
Abstract
PURPOSE Total skin electron irradiation (TSEI) is a radiotherapy technique which consists of an homogeneous body surface irradiation by electrons. This treatment requires very strict technical and dosimetric conditions, requiring the implementation of multiple controls. Recently, the Task Group 100 report of the AAPM has recommended adapting the quality assurance program of the facility to the risks of their processes. MATERIALS AND METHODS A multidisciplinary team evaluated the potential failure modes (FMs) of every process step, regardless of the management tools applied in the installation. For every FM, occurrence (O), severity (S) and detectability (D) by consensus was evaluated, which resulted in the risk priority number (RPN), which permitted the ranking of the FMs. Subsequently, all the management tools used, related to the TSEI process, were examined and the FMs were reevaluated, to analyze the effectiveness of these tools and to propose new management tools to cover the greater risk FMs. RESULTS 361 FMs were identified, 103 of which had RPN ≥80, initially, and 41 had S ≥ 8. Taking this into account the quality management tools FMs were reevaluated and only 30 FMs had RPN ≥80. The study of these 30 FMs emphasized that the FMs that involved greater risk were related to the diffuser screen placement and the patient's position during treatment. CONCLUSIONS The quality assurance program of the facility has been adapted to the risk of this treatment process, following the guidelines proposed by the TG-100. However, clinical experience continually reveals new FMs, so the need for periodic risk analysis is required.
Collapse
Affiliation(s)
- B Ibanez-Rosello
- Radiation Oncology Department, La Fe University and Polytechnic Hospital, Av. Fernando Abril Martorell 106, 46026, Valencia, Spain.
| | - J A Bautista
- Radiation Oncology Department, La Fe University and Polytechnic Hospital, Av. Fernando Abril Martorell 106, 46026, Valencia, Spain
| | - J Bonaque
- Radiation Oncology Department, La Fe University and Polytechnic Hospital, Av. Fernando Abril Martorell 106, 46026, Valencia, Spain
| | - J Perez-Calatayud
- Radiation Oncology Department, La Fe University and Polytechnic Hospital, Av. Fernando Abril Martorell 106, 46026, Valencia, Spain
- Unidad Mixta de Investigación en Radiofísica e Instrumentación Nuclear en Medicina (IRIMED), Instituto de Investigación Sanitaria La Fe (IIS-La Fe)-Universitat de Valencia (UV), 46026, Valencia, Spain
| | - A Gonzalez-Sanchis
- Radiation Oncology Department, ERESA, Hospital General Universitario, 46014, Valencia, Spain
| | - J Lopez-Torrecilla
- Radiation Oncology Department, ERESA, Hospital General Universitario, 46014, Valencia, Spain
| | - L Brualla-Gonzalez
- Medical Physics Department, ERESA, Hospital General Universitario, 46014, Valencia, Spain
| | - T Garcia-Hernandez
- Medical Physics Department, ERESA, Hospital General Universitario, 46014, Valencia, Spain
| | - A Vicedo-Gonzalez
- Medical Physics Department, ERESA, Hospital General Universitario, 46014, Valencia, Spain
| | - D Granero
- Medical Physics Department, ERESA, Hospital General Universitario, 46014, Valencia, Spain
| | - A Serrano
- Medical Physics Department, ERESA, Hospital General Universitario, 46014, Valencia, Spain
| | - B Borderia
- Medical Physics Department, ERESA, Hospital General Universitario, 46014, Valencia, Spain
| | - C Solera
- Medical Physics Department, ERESA, Hospital General Universitario, 46014, Valencia, Spain
| | - J Rosello
- Medical Physics Department, ERESA, Hospital General Universitario, 46014, Valencia, Spain
- Physiology Department, University of Valencia, 46010, Valencia, Spain
| |
Collapse
|
43
|
Geloso MC, Corvino V, Marchese E, Serrano A, Michetti F, D'Ambrosi N. The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches. Front Aging Neurosci 2017; 9:242. [PMID: 28790913 PMCID: PMC5524666 DOI: 10.3389/fnagi.2017.00242] [Citation(s) in RCA: 152] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2017] [Accepted: 07/11/2017] [Indexed: 12/14/2022] Open
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by a non-cell autonomous motor neuron loss. While it is generally believed that the disease onset takes place inside motor neurons, different cell types mediating neuroinflammatory processes are considered deeply involved in the progression of the disease. On these grounds, many treatments have been tested on ALS animals with the aim of inhibiting or reducing the pro-inflammatory action of microglia and astrocytes and counteract the progression of the disease. Unfortunately, these anti-inflammatory therapies have been only modestly successful. The non-univocal role played by microglia during stress and injuries might explain this failure. Indeed, it is now well recognized that, during ALS, microglia displays different phenotypes, from surveillant in early stages, to activated states, M1 and M2, characterized by the expression of respectively harmful and protective genes in later phases of the disease. Consistently, the inhibition of microglial function seems to be a valid strategy only if the different stages of microglia polarization are taken into account, interfering with the reactivity of microglia specifically targeting only the harmful pathways and/or potentiating the trophic ones. In this review article, we will analyze the features and timing of microglia activation in the light of M1/M2 phenotypes in the main mice models of ALS. Moreover, we will also revise the results obtained by different anti-inflammatory therapies aimed to unbalance the M1/M2 ratio, shifting it towards a protective outcome.
Collapse
Affiliation(s)
- Maria Concetta Geloso
- Institute of Anatomy and Cell Biology, Università Cattolica del Sacro CuoreRome, Italy
| | - Valentina Corvino
- Institute of Anatomy and Cell Biology, Università Cattolica del Sacro CuoreRome, Italy
| | - Elisa Marchese
- Institute of Anatomy and Cell Biology, Università Cattolica del Sacro CuoreRome, Italy
| | - Alessia Serrano
- Institute of Anatomy and Cell Biology, Università Cattolica del Sacro CuoreRome, Italy
| | - Fabrizio Michetti
- Institute of Anatomy and Cell Biology, Università Cattolica del Sacro CuoreRome, Italy.,IRCCS San Raffaele Scientific Institute, Università Vita-Salute San RaffaeleMilan, Italy
| | - Nadia D'Ambrosi
- Department of Biology, University of Rome Tor VergataRome, Italy
| |
Collapse
|
44
|
Gutiérrez MC, Serrano A, Siles JA, Chica AF, Martín MA. Centralized management of sewage sludge and agro-industrial waste through co-composting. J Environ Manage 2017; 196:387-393. [PMID: 28334677 DOI: 10.1016/j.jenvman.2017.03.042] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/25/2016] [Revised: 03/14/2017] [Accepted: 03/15/2017] [Indexed: 06/06/2023]
Abstract
In this research study, the co-composting process of a waste mixture containing strawberry extrudate, fish waste, sewage sludge and bulking agent (SEFW, 190:1:22:90 ratio) was carried out in a dynamic-solid respirometer at pilot scale. The aerobic biodegradability of the mixture was previously ensured in a static-liquid respirometer. The advantages and drawbacks of the SEFW co-composting process were subsequently identified through the determination of respirometric activity and the physical-chemical characterization of the waste, as well as the monitoring of odor emissions. The evolution of the physical-chemical variables showed that pH increased slightly and that the organic matter concentration, expressed as volatile solids (VS, %) or oxidable organic carbon (COXC, %), decreased by around 15% in both cases and by approximately 56% in its biodegradable form (total organic carbon, TOC, %). The low odor emission rate (OER) in the least favorable scenario (the maximum odor generation) during SEFW composting was 1.59 ouE/s, whereas this figure reached 3.52 ouE/s when only the organic fraction of municipal solid waste (OFMSW) was composted. Consequently, the co-composting of SEFW is more favorable in terms of odor emission and permits the simultaneous treatment of different types of waste.
Collapse
Affiliation(s)
- M C Gutiérrez
- Department of Inorganic Chemistry and Chemical Engineering, University of Cordoba, Campus Universitario de Rabanales, Edificio Marie Curie (C-3), Ctra. N-IV, km 396, 14071 Cordoba, Spain
| | - A Serrano
- Department of Inorganic Chemistry and Chemical Engineering, University of Cordoba, Campus Universitario de Rabanales, Edificio Marie Curie (C-3), Ctra. N-IV, km 396, 14071 Cordoba, Spain
| | - J A Siles
- Department of Inorganic Chemistry and Chemical Engineering, University of Cordoba, Campus Universitario de Rabanales, Edificio Marie Curie (C-3), Ctra. N-IV, km 396, 14071 Cordoba, Spain
| | - A F Chica
- Department of Inorganic Chemistry and Chemical Engineering, University of Cordoba, Campus Universitario de Rabanales, Edificio Marie Curie (C-3), Ctra. N-IV, km 396, 14071 Cordoba, Spain
| | - M A Martín
- Department of Inorganic Chemistry and Chemical Engineering, University of Cordoba, Campus Universitario de Rabanales, Edificio Marie Curie (C-3), Ctra. N-IV, km 396, 14071 Cordoba, Spain.
| |
Collapse
|
45
|
Fermoso FG, Fernández-Rodríguez MJ, Jiménez-Rodríguez A, Serrano A, Borja R. Suitability of olive oil washing water as an electron donor in a feed batch operating bio-electrochemical system. Grasas y Aceites 2017. [DOI: 10.3989/gya.0216171] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Olive oil washing water derived from the two-phase manufacturing process was assessed as an electron donor in a bio-electrochemical system (BES) operating at 35 ºC. Start-up was carried out by using acetate as a substrate for the BES, reaching a potential of around +680 mV. After day 54, BES was fed with olive oil washing water. The degradation of olive oil washing water in the BES generated a maximum voltage potential of around +520 mV and a Chemical Oxygen Demand (COD) removal efficiency of 41%. However, subsequent loads produced a decrease in the COD removal, while current and power density diminished greatly. The deterioration of these parameters could be a consequence of the accumulation of recalcitrant or inhibitory compounds, such as phenols. These results demonstrated that the use of olive oil washing water as an electron donor in a BES is feasible, although it has to be further investigated in order to make it more suitable for a real application.
Collapse
|
46
|
García-Marchena N, Araos P, Barrios V, Sanchez-Marin L, Chowen J, Ponce G, Argente J, Rubio G, Serrano A, de Fonseca FR, Pavon F. Evaluation of plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with comorbid mental disorders. Alcohol 2017. [DOI: 10.1016/j.alcohol.2017.02.327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
47
|
Ibanez-Rosello B, Bautista-Ballesteros J, Bonaque J, Perez-Calatayud J, Gonzalez-Sanchis A, Lopez-Torrecilla J, Brualla-Gonzalez L, Garcia- Hernandez M, Vicedo-Gonzalez A, Granero D, Serrano A, Borderia B, Rosello J. EP-1744: Failure modes and effects analysis of Total Skin Electron Irradiation (TSEI) technique. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)32107-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
48
|
Hernandez RE, Gerson R, Olivares G, Rivera S, Serrano A, Villalobos A, Lazaro M. Abstract P5-11-13: Experience in the ABC Medical Center of Mexico City 2010-2015 using scalp-cooling system (DigniCap) for prevention of alopecia induced by chemotherapy. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p5-11-13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Alopecia is one of the secondary side effect whit the most emotionally impact for patients undergoing chemotherapy (CTX) The DigniCap System is the first scalp cooling system use to minimize alopecia. Methods: The objetive of this study was to evaluate in a restrospective trial the efficacy of DigniCap preventing alopecia in consecutive patients treated in ABC Medical Center from December 2010 to January 2015. Patients recieve different chemotherapy regimens, with different modalities, neo , adyuvant and for metastases in first and second line, as in many clinical stages whit breast cancer (BC), were evaluated with the visual scale of Dean (score 0: 0-25%, 1: 25-50%, 2: 50-75%, 3: 75-100%) with photographs of the before and after treatment. Results: 120 pts with BC in stages I-V were treated with a taxane and antraciclins regimen of chemotherapy, 66 pts receive 12 treatment weekly of paclitaxe (T)l and 4 adriamicin/cyclophosphamida (AC) every 21 days, 28 pts 6-8 cycles every 21 days AC-Taxol, 22 pts (18%)suspended the treatment because of the loss of more than 50% of hair at the 2nd an 3rd chemotherapy cycle. 98 pts actually finished the treatment (72%). Of these, 82 pts (84%) no had or had a minimal loss of hair (Dean score 0-1), 16 pts (16%) had a 50% of hair loss (Dean score 3). 8pts recieve more than one regimen of chemotherapy. In the tracing any metastases or side effects were presented with the use of DigniCap. Conclusions: The use of DigniCap minimize alopecia in a 84%, including pts with more than one chemotherapy regimen, in a a safety level.
Citation Format: Hernandez RE, Gerson R, Olivares G, Rivera S, Serrano A, Villalobos A, Lazaro M. Experience in the ABC Medical Center of Mexico City 2010-2015 using scalp-cooling system (DigniCap) for prevention of alopecia induced by chemotherapy [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P5-11-13.
Collapse
Affiliation(s)
| | - R Gerson
- Centro Medico ABC, Mexico, Mexico
| | | | - S Rivera
- Centro Medico ABC, Mexico, Mexico
| | | | | | - M Lazaro
- Centro Medico ABC, Mexico, Mexico
| |
Collapse
|
49
|
Serrano M, Cabrera-Marante O, Martínez-Flores JA, Morales P, Pérez D, Mora S, García F, González E, Paz-Artal E, Morales JM, Serrano A. Study of β 2-Glycoprotein I Polymorphisms in Patients With Chronic Renal Failure as a Predisposing Factor for the Development of Anti-β 2-Glycoprotein I Auto-Antibodies. Transplant Proc 2016; 48:2876-2879. [PMID: 27932096 DOI: 10.1016/j.transproceed.2016.07.040] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2016] [Accepted: 07/27/2016] [Indexed: 10/20/2022]
Abstract
BACKGROUND Immunoglobulin (Ig)A anti-β2-glycoprotein I (aB2GP1) antibodies are associated with thrombotic events, cardiovascular morbidity, and death in dialysis patients. About 30% of patients with chronic renal disease are positive for IgA aB2GP1; however, the origin of these antibodies is unknown. It has been speculated that dialysis membranes, age, or etiology of renal base disease are possible precipitating factors, although these factors do not appear to be the source of antibodies. B2GP1 is a protein of 326 amino acids grouped into five domains. Eight polymorphisms have been described; the most important are Val/Leu247, which appears to predispose aB2GP1 antibody production in patients with anti-phospholipid syndrome, and Trp/Ser316, which appears to have protective antibody production of aB2GP1. METHODS DNA samples from 92 patients with renal failure on hemodialysis were randomly collected with a 1:1 ratio for the positivity for IgA aB2GP1. Forty-six samples were positive for IgA aB2GP1 (group 1) and 46 negative for IgA aB2GP1 (group 2). All samples were anonymized to study polymorphism Val/Leu247 and polymorphism Trp/Ser316. RESULTS No significant differences were observed between those who were positive or negative for IgA aB2GP1 in patients with renal failure treated with hemodialysis and the polymorphism located in codons 247 and 316. CONCLUSIONS The two groups of patients have the same prevalence in polymorphisms 247 and 316, and therefore there appears not to be a genetic predisposition in our population. New trigger factors must be studied.
Collapse
Affiliation(s)
- M Serrano
- Department of Immunology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - O Cabrera-Marante
- Department of Immunology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - J A Martínez-Flores
- Department of Immunology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - P Morales
- Department of Immunology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - D Pérez
- Department of Immunology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - S Mora
- Department of Immunology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - F García
- Department of Nephrology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - E González
- Department of Nephrology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - E Paz-Artal
- Department of Immunology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain; Immunology Section, Universidad San Pablo-CEU, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Spain
| | - J M Morales
- Department of Immunology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - A Serrano
- Department of Immunology, Instituto de Investigación, Hospital Universitario 12 de Octubre, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Spain.
| |
Collapse
|
50
|
De la Rosa Kehrmann F, García González L, Pamplona Casamayor M, Rodríguez Antolín A, Duarte Ojeda J, Villacampa Aubá F, Medina Polo J, González Monte E, Serrano A, Passas Martínez J. Association entre la perte précoce de la greffe et la présence des anticorps IgA préformes dirigés contre β2 glycoprotéine I. Prog Urol 2016. [DOI: 10.1016/j.purol.2016.07.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|